-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$2.68 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$14.25 M
Akero Therapeutics, Inc. Insider Transactions
Akero Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Rolph Timothy
Chief Scientific Officer |
Sell | 619 @ $28.33 | $17,536 | 182,558 | 03/13/2024 | 03/15/2024 | |
|
Cheng Andrew
CEO |
Sell | 35,827 @ $31.40 | $1.12 M | 630,589 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 6,770 @ $32.28 | $218,538 | 623,819 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 9,614 @ $33.83 | $325,267 | 614,205 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 14,680 @ $34.63 | $508,373 | 599,525 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 7,995 @ $35.49 | $283,775 | 591,530 | 03/04/2024 | 03/06/2024 | |
|
Cheng Andrew
CEO |
Sell | 114 @ $36.28 | $4,136 | 591,416 | 03/04/2024 | 03/06/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 20,646 @ $35.49 | $732,727 | 78,415 | 03/04/2024 | 03/06/2024 | |
|
Young Jonathan
COO |
Sell | 5,414 @ $24.00 | $129,936 | 185,131 | 12/27/2023 | 12/29/2023 | |
|
Yale Catriona
Chief Development Officer |
Sell | 597 @ $20.76 | $12,394 | 77,910 | 12/14/2023 | 12/18/2023 | |
| Sell | 611 @ $20.76 | $12,684 | 50,354 | 12/14/2023 | 12/18/2023 | ||
|
Young Jonathan
COO |
Sell | 543 @ $20.76 | $11,273 | 185,131 | 12/14/2023 | 12/18/2023 | |
|
Cheng Andrew
CEO |
Sell | 1,628 @ $20.76 | $33,797 | 550,911 | 12/14/2023 | 12/18/2023 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 514 @ $20.76 | $10,671 | 182,672 | 12/14/2023 | 12/18/2023 | |
|
Cheng Andrew
CEO |
Sell | 7,405 @ $20.02 | $148,273 | 552,539 | 12/11/2023 | 12/11/2023 | |
|
Graham G. Walmsley
Director |
Buy | 50,000 @ $19.80 | $990,240 | 750,000 | 12/08/2023 | 12/11/2023 | |
|
Cheng Andrew
CEO |
Sell | 12,873 @ $20.01 | $257,571 | 460,998 | 12/08/2023 | 12/11/2023 | |
|
Cheng Andrew
CEO |
Sell | 6,700 @ $20.02 | $134,125 | 460,998 | 12/07/2023 | 12/11/2023 | |
|
Graham G. Walmsley
Director |
Buy | 50,000 @ $16.99 | $849,730 | 700,000 | 12/01/2023 | 12/05/2023 | |
|
Graham G. Walmsley
Director |
Buy | 50,000 @ $16.90 | $844,835 | 650,000 | 11/30/2023 | 12/05/2023 |
Akero Therapeutics, Inc. Frequently Asked Questions
-
Who is on Akero Therapeutics, Inc.'s Insider Roster?
The list of insiders at Akero Therapeutics, Inc. includes Young Jonathan, Cheng Andrew, Graham G. Walmsley, Rolph Timothy, White William Richard, Yale Catriona, Lamy Patrick.
-
How much insider selling is happening at Akero Therapeutics, Inc.?
Insiders have sold a total of 512,091 Akero Therapeutics, Inc. shares in the last 12 months for a total of 14.25 M sold.
-
Which Akero Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Akero Therapeutics, Inc. shares in the last 12 months: Young Jonathan ($1.40 M), Cheng Andrew ($4.52 M), Rolph Timothy ($96,151), White William Richard ($6.58 M), Yale Catriona ($1.64 M), Lamy Patrick ($12,883),
-
How much insider buying is happening at Akero Therapeutics, Inc.?
Insiders have purchased a total of 150,000 Akero Therapeutics, Inc. shares in the last 12 months for a total of 2.68 M sold.
-
Which Akero Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Akero Therapeutics, Inc. shares in the last 12 months: Graham G. Walmsley ($2.68 M),